海正生材10月10日获融资买入731.61万元，融资余额7333.58万元

Core Viewpoint - On October 10, 2023, Zhejiang Haizheng Biomaterials Co., Ltd. experienced a stock decline of 3.02%, with a trading volume of 54.72 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing Summary - On the same day, the company had a financing buy-in amount of 7.32 million yuan and a financing repayment of 3.66 million yuan, resulting in a net financing buy-in of 3.66 million yuan [1]. - As of October 10, the total financing and securities lending balance for the company was 73.34 million yuan, which represents 4.18% of its circulating market value, indicating a high level of financing activity compared to the past year [1]. - The company had no securities lending activity on October 10, with both securities lent and repaid being zero, reflecting a lack of short-selling interest [1]. Business Performance - As of June 30, 2025, the number of shareholders increased by 11.75% to 7,457, while the average circulating shares per person decreased by 10.51% to 15,787 shares [2]. - For the first half of 2025, the company reported a revenue of 408 million yuan, a year-on-year decrease of 5.28%, and a net profit attributable to shareholders of 3.18 million yuan, down 87.32% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 42.49 million yuan in dividends [2]. Shareholding Structure - As of June 30, 2025, among the top ten circulating shareholders, Guangfa Technology Innovation Mixed A (008638) was the fifth largest shareholder, holding 7.05 million shares as a new investor [2].